Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Tecnología de cribado virtual basada en aprendizaje profundo y big data

Resumen

Tipo:
Demanda Tecnológica
Referencia:
TRKR20181107001
Publicado:
09/01/2019
Caducidad:
10/01/2020
Resumen:
Una compañía farmacéutica coreana fundada en 2018 está especializada en investigación y desarrollo de nuevos medicamentos basados en productos naturales y enfermedades huérfanas mediante tecnología de cribado virtual basada en inteligencia artificial (IA). La tecnología que quiere desarrollar la empresa es una tecnología de cribado virtual basada en aprendizaje profundo mediante el uso de big data. La empresa está planificando el desarrollo de nuevos medicamentos con mejores funciones para su aplicación en enfermedades huérfanas y generales. La cooperación se establecerá en el marco de un acuerdo comercial con asistencia técnica.

Details

Tittle:
Virtual screening technology based on deep learning using big data
Summary:
A Korean pharmaceutical company is active in research and development of new drugs based on natural products and orphan disease through virtual screening technology on the basis of AI. The technology that the company wants to develop by cooperation is virtual screening technology based on deep learning using big data. The type of partnership is commercial agreement with technical assistance.
Description:
A Korean company is a pharmaceutical-based and established in 2018.

The company specializes in development of new drugs of orphan diseases with a use of virtual screening technology. The company comes up with the idea of the new drugs based on natural products due to treatment of orphan diseases and senile diseases in a short period of time, which result in high quality of life eventually.

The company is planning on development of new drugs with improved functions that would enable to be applied on orphan disease and general diseases with partners under commercial agreement with technical assistant.
Technical Specification or Expertise Sought:
Reducing the time of development of new drugs as well as reducing the risk of failure result in costs for research and development ultimately. As technology is a competitive advantage, it will lead the world pharmaceutical market. Also, pharmaceutical and bio-pharma and engineering technology based on IT software are fused to create new values, which could provide new industries and jobs eventually.

Partner sought

Type and Role of Partner Sought:
- Type of partner: Technological SME or large enterprise is preferable with experience in Big data(AI)

- Specific area of activity of the partner: Any partner specialized in the technology for screening technology based on deep learning using big data

- Task to be performed: Partners should engage in pharmaceutical companies or research institute or specialize in virtual screening technology in the basis of deep-learning to develop new drugs on orphan disease under commercial agreement with technical assistance.

Client

Type and Size of Client:
Industry SME 11-49
Already Engaged in Trans-National Cooperation:
No
Languages Spoken:
English